MOD-9017
/ OPKO Health
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 07, 2011
Investor Conference Call
(Prolor-Biotech)
- Factor IX-CTP / Prolor Biotech; Anticipated P2 study regulatory clearance in Q2 & Q3 '12
Anticipated P2 regulatory clearance • Hemophilia
1 to 1
Of
1
Go to page
1